3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Lymphoma
5
Central Nervous System Neoplasms
4
Neuroblastoma
2
Meningeal Carcinomatosis
2
Brain Neoplasms
2
Vasculitis, Central Nervous System
1
Thrombocytopenia
1
Stiff-Person Syndrome
1
Rhabdoid Tumor
1
Recurrence
1
Rasmussen subacute encephalitis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
1
Opsoclonus-Myoclonus Syndrome
1
Neurotoxicity Syndromes
1
Neuromyelitis Optica
1
Neurofibromatosis 1
1
Myasthenia Gravis
1
Medulloblastoma
1
Lymphoma, Non-Hodgkin
1
Leukemia, Myelomonocytic, Juvenile
1
Leukemia, Myeloid, Acute
1
Leukemia
1
Lambert-Eaton Myasthenic Syndrome
1
Intraocular Lymphoma
1
HIV Infections
1
Ependymoma
1
Drug-Related Side Effects and Adverse Reactions
1
Breast Neoplasms
1
Autoimmune Diseases of the Nervous System
1
Interventions
Cyclophosphamide
35
Temozolomide
33
Filgrastim
26
Etoposide
26
Carboplatin
25
Vincristine
22
Cisplatin
22
Radiotherapy
20
Magnetic Resonance Spectroscopy
18
Thiotepa
14
Irinotecan
13
Granulocyte Colony-Stimulating Factor
12
Peripheral Blood Stem Cell Transplantation
11
Lomustine
11
Specimen Handling
9
Radiation
9
Melphalan
9
etoposide phosphate
8
Topotecan
8
Methotrexate
8
X-Rays
7
Platinum
7
Phantoms, Imaging
7
sonidegib
6
Biopsy
6
1,2-diaminocyclohexaneplatinum II citrate
6
sargramostim
5
palbociclib
5
Nuclear Medicine Department, Hospital
5
HhAntag691
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Medulloblastoma
×
Cytarabine
×
CNS
×
Clear all
NCT01356290
2026-02-23
MEMMAT
Medical University of Vienna
Phase 2
Recruiting
232 enrolled